Call for spontaneous reports of adverse drug events from indian physicians- need of the hour [1]

Journal of Association of Physicians of India

Volumn 55, Issue AUG., 2007, Pages 597-598

  Gogtay, N J ^a   Kshirsagar, N A ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; HUMAN; INDIA; LETTER; PHYSICIAN; TIME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG TOXICITY; HUMANS; INDIA; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; TIME FACTORS;

EID: 34547635664     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical department of the Emergency Services of a tertiary referral centre. BMC Clinical Pharmacology (in press).
2. Mohan V, Joshi SR. The Rosiglitazone controversy: The Indian perspective. J Assoc Physicians India 2007;55:477-80.
3. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine and rimonabant. Lancet 2007;369:71-7.
4. Protocol of the National Pharmacovigilance Program of India. Central Drugs Standard Control Organization, Ministry of Health and Family Welfare, Govt. of India, November 2004.